Study of OT202 in Treating Moderate to Severe Dry Eye

PHASE2CompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

January 26, 2024

Study Completion Date

January 26, 2024

Conditions
Dry Eye
Interventions
DRUG

OT202 conc 0.5%

Apply 1-2 drops of OT202 0.5% solution into the conjunctival sac. three times daily

DRUG

OT202 conc 0.1%

Apply 1-2 drops of OT202 0.1% solution into the conjunctival sac. three times daily

DRUG

Placebo

Apply 1-2 drops of placebo solution into the conjunctival sac. three times daily

Trial Locations (10)

Unknown

The Third Xiangya Hospital Of Central South University, Changsha

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

Then Second People's Hospital of Yunnan Province, Kunming

Ning Bo Eye Hospital, Ningbo

Tianjin Eye Hospital, Tianjin

Tianjin Medical University Eye Hospital, Tianjin

Eye Hospital, WMU, Wenzhou

Renmin Hospital of Wuhan University, Wuhan

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors
lead

Ocumension Therapeutics (Shanghai) Co., Ltd

INDUSTRY